
    
      This is a 1-year study and a randomized, double-blind, and placebo controlled Clinical the
      study. investigators plan to enrol 100 subjects from Child and Adolescent Psychiatry
      Outpatient Clinic of China Medical University Hospital.Participants will be randomized into
      omega-3 polyunsaturated fatty acids or placebo group.The intervention period is 12 weeks.
      Evaluation of the cognitive function ( using Continuous Performance Test 3rd Edition ) of the
      subjects who are enrolled into the study will take place at baseline and after the 12th week.
      The symptom severity of ADHD will be measured with Swanson, Nolan, Pelham Questionnaire
      (SNAP-IV) at baseline, 2,4,8, and 12 weeks. The plasma level of n-3 polyunsaturated fatty
      acids, blood and salivary inflammatory markers will also be measured at the beginning and at
      the end of the study.
    
  